#6 - UnitedHealth Group (NYSE:UNH)
UnitedHealth Group International (NYSE: UNH) is one of the leading healthcare and health insurance companies in the United States. The company announced a $3 billion share buyback program in March 2024. But this is just a continuation of a series of buyback initiatives taken by the company.
UNH stock is down about 4% in 2024 but has been rallying since its earnings report in April. The stock is up 9% after the company posted revenue and earnings that beat expectations and were higher year-over-year. The company has also had to deal with the fallout from a cyberattack, but that appeared to be not as bad as feared.
Analysts maintain a Moderate Buy rating for UNH stock and have a consensus price target of approximately $570. UNH has a buyback yield of 1.8% and a dividend yield of 1.42%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More - Current Price
- $500.13
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 19 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $626.84 (25.3% Upside)
